{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6
  ],
  "modelUsed": "claude-opus-4-5",
  "interventions": {
    "studyInterventions": [
      {
        "id": "int_1",
        "name": "Isatuximab",
        "role": {
          "code": "Investigational Product",
          "codeSystem": "USDM",
          "decode": "Investigational Product"
        },
        "instanceType": "StudyIntervention",
        "description": "Anti-CD38 monoclonal antibody administered as IV infusion",
        "productIds": [
          "prod_1"
        ],
        "administrationIds": [
          "admin_1"
        ]
      },
      {
        "id": "int_2",
        "name": "Atezolizumab",
        "role": {
          "code": "Investigational Product",
          "codeSystem": "USDM",
          "decode": "Investigational Product"
        },
        "instanceType": "StudyIntervention",
        "description": "Anti-PD-L1 monoclonal antibody administered as IV infusion in combination with isatuximab",
        "productIds": [
          "prod_2"
        ],
        "administrationIds": [
          "admin_2"
        ]
      }
    ],
    "administrableProducts": [
      {
        "id": "prod_1",
        "name": "Isatuximab",
        "instanceType": "AdministrableProduct",
        "doseForm": {
          "code": "Solution",
          "codeSystem": "USDM",
          "decode": "Solution"
        },
        "substanceIds": [
          "sub_1"
        ],
        "manufacturer": "Sanofi"
      },
      {
        "id": "prod_2",
        "name": "Atezolizumab",
        "instanceType": "AdministrableProduct",
        "doseForm": {
          "code": "Solution",
          "codeSystem": "USDM",
          "decode": "Solution"
        },
        "substanceIds": [
          "sub_2"
        ]
      }
    ],
    "administrations": [
      {
        "id": "admin_1",
        "name": "Isatuximab Cycle 1",
        "instanceType": "Administration",
        "doseFrequency": "Day 1, Day 8, Day 15",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "21-day cycle"
      },
      {
        "id": "admin_2",
        "name": "Isatuximab Cycle 2 and Beyond",
        "instanceType": "Administration",
        "doseFrequency": "Day 1 of each 21-day cycle",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "Until disease progression or discontinuation"
      },
      {
        "id": "admin_3",
        "name": "Atezolizumab",
        "instanceType": "Administration",
        "doseFrequency": "Day 1 of each 21-day cycle",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "Until disease progression or discontinuation"
      }
    ],
    "substances": [
      {
        "id": "sub_1",
        "name": "isatuximab",
        "instanceType": "Substance",
        "description": "Anti-CD38 monoclonal antibody"
      },
      {
        "id": "sub_2",
        "name": "atezolizumab",
        "instanceType": "Substance",
        "description": "Anti-PD-L1 monoclonal antibody"
      }
    ],
    "medicalDevices": [],
    "summary": {
      "interventionCount": 2,
      "productCount": 2,
      "deviceCount": 0
    }
  },
  "rawResponse": {
    "interventions": [
      {
        "name": "Isatuximab",
        "role": "Investigational Product",
        "description": "Anti-CD38 monoclonal antibody administered as IV infusion"
      },
      {
        "name": "Atezolizumab",
        "role": "Investigational Product",
        "description": "Anti-PD-L1 monoclonal antibody administered as IV infusion in combination with isatuximab"
      }
    ],
    "products": [
      {
        "name": "Isatuximab",
        "doseForm": "Solution for infusion",
        "strength": "",
        "manufacturer": "Sanofi"
      },
      {
        "name": "Atezolizumab",
        "doseForm": "Solution for infusion",
        "strength": "",
        "manufacturer": ""
      }
    ],
    "substances": [
      {
        "name": "isatuximab",
        "description": "Anti-CD38 monoclonal antibody"
      },
      {
        "name": "atezolizumab",
        "description": "Anti-PD-L1 monoclonal antibody"
      }
    ],
    "administrations": [
      {
        "name": "Isatuximab Cycle 1",
        "dose": "",
        "frequency": "Day 1, Day 8, Day 15",
        "route": "Intravenous",
        "duration": "21-day cycle"
      },
      {
        "name": "Isatuximab Cycle 2 and Beyond",
        "dose": "",
        "frequency": "Day 1 of each 21-day cycle",
        "route": "Intravenous",
        "duration": "Until disease progression or discontinuation"
      },
      {
        "name": "Atezolizumab",
        "dose": "",
        "frequency": "Day 1 of each 21-day cycle",
        "route": "Intravenous",
        "duration": "Until disease progression or discontinuation"
      }
    ],
    "devices": []
  }
}